Atomoxetine 60 MG Oral Capsule — RxCUI 349595
RxNorm drug concept · Semantic clinical drug
RxCUI 349595
Semantic clinical drug · SCD
● Current RxNorm concept 100 FDA products
144 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI349595
Official nameAtomoxetine 60 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatomoxetine 60 MG (as atomoxetine hydrochloride) Oral Capsule; atomoxetine HCl 60 MG Oral Capsule
FDA products mapped100
Package NDCs mapped144
Reported Medicaid activity (SDUD)1,684,822 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Atomoxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No — atomoxetine is not a stimulant. It works differently from medications like amphetamines or methylphenidate. Instead of stimulating the brain directly, it blocks the reuptake o...
- Is atomoxetine a stimulant like other ADHD medications?
- Atomoxetine typically takes several weeks to reach its full effect — it's not something you'll feel on the first day. Your prescriber will usually start you on a lower dose and gra...
- How long does it take before I notice atomoxetine working?
🕸️ Concept Web — How Atomoxetine 60 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Atomoxetine 60 MG Oral Capsule
RxCUI 349595 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Atomoxetine
38400IN
-
Atomoxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Strattera
358330BN
-
Strattera
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Atomoxetine Oral Capsule
378308SCDF -
Atomoxetine Oral Product
1158282SCDG -
Atomoxetine Pill
1158283SCDG -
Atomoxetine Oral Capsule [Strattera]
366499SBDF -
Strattera Oral Product
1180205SBDG -
Strattera Pill
1180206SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Atomoxetine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Atomoxetine 60 MG
350677SCDC -
Atomoxetine 60 MG Oral Capsule [Strattera]
352321SBD -
Atomoxetine 60 MG [Strattera]
576015SBDC
-
Atomoxetine 60 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Atomoxetine 60 MG
SCDC · 350677 -
Atomoxetine Oral Capsule
SCDF · 378308 -
Atomoxetine Oral Product
SCDG · 1158282 -
Atomoxetine Pill
SCDG · 1158283
Brand-Name Concepts
-
Atomoxetine 60 MG Oral Capsule [Strattera]
SBD · 352321 -
Atomoxetine 60 MG [Strattera]
SBDC · 576015 -
Atomoxetine Oral Capsule [Strattera]
SBDF · 366499 -
Strattera Oral Product
SBDG · 1180205 -
Strattera Pill
SBDG · 1180206 -
Strattera
BN · 358330
📦 FDA Products & Package NDCs
100 products · 144 package NDCs
144 package NDCs map to RxCUI 349595 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-3227-30 | 30 CAPSULE in 1 BOTTLE (0002-3227-30) | Strattera | Eli Lilly and Company | 2003-01-10 |
| 00002-3228-30 | 30 CAPSULE in 1 BOTTLE (0002-3228-30) | Strattera | Eli Lilly and Company | 2003-01-10 |
| 00002-3229-30 | 30 CAPSULE in 1 BOTTLE (0002-3229-30) | Strattera | Eli Lilly and Company | 2003-01-10 |
| 00002-3238-30 | 30 CAPSULE in 1 BOTTLE (0002-3238-30) | Strattera | Eli Lilly and Company | 2003-01-10 |
| 00002-3239-30 | 30 CAPSULE in 1 BOTTLE (0002-3239-30) | Strattera | Eli Lilly and Company | 2003-01-10 |
| 00002-3250-30 | 30 CAPSULE in 1 BOTTLE (0002-3250-30) | Strattera | Eli Lilly and Company | 2005-08-24 |
| 00002-3251-30 | 30 CAPSULE in 1 BOTTLE (0002-3251-30) | Strattera | Eli Lilly and Company | 2005-08-24 |
| 00093-3542-56 | 30 CAPSULE in 1 BOTTLE (0093-3542-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3543-56 | 30 CAPSULE in 1 BOTTLE (0093-3543-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3544-56 | 30 CAPSULE in 1 BOTTLE (0093-3544-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3545-56 | 30 CAPSULE in 1 BOTTLE (0093-3545-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3546-56 | 30 CAPSULE in 1 BOTTLE (0093-3546-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3547-56 | 30 CAPSULE in 1 BOTTLE (0093-3547-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 00093-3548-56 | 30 CAPSULE in 1 BOTTLE (0093-3548-56) | Atomoxetine | Teva Pharmaceuticals USA, Inc. | 2017-05-30 |
| 16714-0755-01 | 30 CAPSULE in 1 BOTTLE (16714-755-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0756-01 | 30 CAPSULE in 1 BOTTLE (16714-756-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0757-01 | 30 CAPSULE in 1 BOTTLE (16714-757-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0758-01 | 30 CAPSULE in 1 BOTTLE (16714-758-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0759-01 | 30 CAPSULE in 1 BOTTLE (16714-759-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0760-01 | 30 CAPSULE in 1 BOTTLE (16714-760-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 16714-0761-01 | 30 CAPSULE in 1 BOTTLE (16714-761-01) | atomoxetine | Northstar Rx LLC | 2018-06-01 |
| 31722-0714-30 | 30 CAPSULE in 1 BOTTLE (31722-714-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0715-30 | 30 CAPSULE in 1 BOTTLE (31722-715-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0716-30 | 30 CAPSULE in 1 BOTTLE (31722-716-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0717-30 | 30 CAPSULE in 1 BOTTLE (31722-717-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0718-30 | 30 CAPSULE in 1 BOTTLE (31722-718-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0719-30 | 30 CAPSULE in 1 BOTTLE (31722-719-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 31722-0720-30 | 30 CAPSULE in 1 BOTTLE (31722-720-30) | Atomoxetine | Camber Pharmaceuticals, Inc. | 2021-03-11 |
| 42291-0064-30 | 30 CAPSULE in 1 BOTTLE (42291-064-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0065-30 | 30 CAPSULE in 1 BOTTLE (42291-065-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0066-30 | 30 CAPSULE in 1 BOTTLE (42291-066-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0067-30 | 30 CAPSULE in 1 BOTTLE (42291-067-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0068-30 | 30 CAPSULE in 1 BOTTLE (42291-068-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0069-30 | 30 CAPSULE in 1 BOTTLE (42291-069-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 42291-0070-30 | 30 CAPSULE in 1 BOTTLE (42291-070-30) | Atomoxetine | AvKARE | 2022-04-12 |
| 50090-6254-00 | 30 CAPSULE in 1 BOTTLE (50090-6254-0) | Atomoxetine | A-S Medication Solutions | 2022-12-02 |
| 50090-6444-00 | 30 CAPSULE in 1 BOTTLE (50090-6444-0) | Atomoxetine | A-S Medication Solutions | 2023-04-19 |
| 50090-7397-00 | 30 CAPSULE in 1 BOTTLE (50090-7397-0) | atomoxetine | A-S Medication Solutions | 2024-10-23 |
| 50268-0059-13 | 30 BLISTER PACK in 1 BOX (50268-059-13) / 1 CAPSULE in 1 BL... | Atomoxetine Hydrochloride | AvPAK | 2020-07-07 |
| 51407-0100-30 | 30 CAPSULE in 1 BOTTLE (51407-100-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0101-30 | 30 CAPSULE in 1 BOTTLE (51407-101-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0102-30 | 30 CAPSULE in 1 BOTTLE (51407-102-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0103-30 | 30 CAPSULE in 1 BOTTLE (51407-103-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0104-30 | 30 CAPSULE in 1 BOTTLE (51407-104-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0105-30 | 30 CAPSULE in 1 BOTTLE (51407-105-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 51407-0106-30 | 30 CAPSULE in 1 BOTTLE (51407-106-30) | Atomoxetine Hydrochloride | Golden State Medical Supply, Inc. | 2018-06-07 |
| 55111-0519-05 | 500 CAPSULE in 1 BOTTLE (55111-519-05) | Atomoxetine | Dr. Reddy's Laboratories Limited | 2018-02-23 |
| 55111-0519-30 | 30 CAPSULE in 1 BOTTLE (55111-519-30) | Atomoxetine | Dr. Reddy's Laboratories Limited | 2018-02-23 |
| 55111-0519-78 | 100 BLISTER PACK in 1 CARTON (55111-519-78) / 10 CAPSULE in... | Atomoxetine | Dr. Reddy's Laboratories Limited | 2018-02-23 |
| 55111-0520-05 | 500 CAPSULE in 1 BOTTLE (55111-520-05) | Atomoxetine | Dr. Reddy's Laboratories Limited | 2018-02-23 |
Observed labelers:
Dr. Reddy's Laboratories Limited (21) ·
Aurobindo Pharma Limited (14) ·
Glenmark Pharmaceuticals Inc., USA (14) ·
Strides Pharma Science Limited (14) ·
Rising Pharma Holdings, Inc. (9) ·
Apotex Corp. (7)
· +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.